AstraZeneca Highlights Oncology and ADC Progress at ESMO Conference
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
AstraZeneca showcased its major momentum and advancements in oncology, highlighting antibody-drug conjugates for lung and gastric cancer during a prominent presentation at Europe's top cancer conference.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu